What's new | 2ページ目 (3ページ中)

TOP What’s new

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…
2025.07.30
Notices

Notice of Summer Holiday Closure
2025.06.26
Notices

Notice of Change in Representative Direc…
2025.03.07
Clinical Trial Progress

Providing our developed antibody drug (P…
2025.01.31
Funding-related

In addition to the additional investment…
2024.10.03
Notices

We will be exhibiting at the Japan Healt…
2024.09.18
Media Relations

Selected for the 2024 edition of Toyo Ke…
2024.06.27
Funding-related

In addition to the Series D/D1 round of …
2024.04.30
Joint Research and Licensing

We have signed a joint research agreemen…

News

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

We will be exhibiting at the Japan Healt…

Our Company Highlighted in FUJIFILM Wako…

Notice of Summer Holiday Closure

Notice of Change in Representative Direc…

Providing our developed antibody drug (P…

In addition to the additional investment…

We will be exhibiting at the Japan Healt…

Selected for the 2024 edition of Toyo Ke…

In addition to the Series D/D1 round of …

We have signed a joint research agreemen…

Contact